Basic Documentation
Table Of Contents
- Hospital Pharmacy–USP Compounding Standards
- Environmental Requirements for USP 795 & 797 Compliance
- Current USP Guidelines
- Center for Medicare and Medicaid Services (CMS) Compliance Date
- USP <795> Facility Requirements
- USP <797> Facility Requirements
- Equipment (Primary Controls)
- Design Requirements for CSP Pharmacies
- Building Exhaust Design Considerations
- Cleanroom Design Considerations
- HVAC Design Considerations
- Certification and Recertification
- Monitoring Controlled Storage Areas
Technology Report
September, 2018
Siemens Industry, Inc. Page 1 of 8
Document No. 149-224
Hospital Pharmacy–USP Compounding Standards
Environmental Requirements for USP 795 & 797 Compliance
This technology report summarizes the
environmental requirements for compounded sterile
preparations (CSPs) and for compounded nonsterile
preparations (CNSPs). Compounding occurs in the
following settings:
• Hospitals
• Outpatient treatment clinics
• Infusion facilities
• Pharmacies
• Physician offices
• Long-term care facilities
This report is based on the current industry
guidelines listed in the following section, as well as
the experience of knowledgeable healthcare facility
designers.
Regulatory requirements constantly evolve.
This technology report is based on United States
Pharmacopeia (USP) <797> proposed revision
dated July 2018 and USP <795> proposed
revision dated March 2018.
Section 503A of the Federal Food, Drug, and
Cosmetic Act states that compounded
preparations prepared by a licensed pharmacist
or physician qualify for an exemption from the
requirements of current Good Manufacturing
Practice (cGMP) if they are compounded in
compliance with the USP chapters on pharmacy
compounding
1
.
Current USP Guidelines
• The current version of USP <795> became
official on January 1, 2014.
• An update to USP <795> was proposed for
public comment on March 30, 2018.
• The proposed update to USP <795> is expected
to be official on December 1, 2019.
1. The FD&C ACT section 503A contains additional exemption
requirements.
• The current version of USP <797> became
official on June 1, 2008.
• An update to USP <797> was proposed for
public comment on July 27, 2018.
• The proposed update to USP <797> is expected
to be official on December 1, 2019.
Center for Medicare and Medicaid
Services (CMS) Compliance Date
• October 30, 2015–Condition of Participation
was updated to require hospitals to comply with
USP <797> and other relevant USP-NF
(National Formulary) chapters.
USP <795> Facility Requirements
USP <795> describes the minimum practices and
quality standards for the preparation of CNSPs.
CNSPs must be prepared in a space that is
specifically designated for compounding. The
compounding area must be separated from the rest
of the facility. Nonsterile preparations must be
compounded in a separate and distinct space from
sterile compounding.
Any activity that may result in airborne contamination
(powder substance) must be performed in a
containment ventilated enclosure (CVE).
CVE
A full or partial enclosure that uses ventilation
principles to capture, contain, and remove
airborne contaminates through high-efficiency
particulate air (HEPA) filtration
USP <797> Facility Requirements
USP <797> describes the minimum practices and
quality standards for the preparation of CSPs.